Steve Schonfeld’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $617K | Buy |
+2,649
| New | +$612K | ﹤0.01% | 1865 |
|
|
2025
Q3 | – | Sell |
-25,389
| Closed | -$4.56M | – | 2273 |
|
|
2025
Q2 | $4.56M | Buy |
25,389
+8,366
| +49% | +$1.45M | 0.03% | 596 |
|
|
2025
Q1 | $2.88M | Sell |
17,023
-2,077
| -11% | -$341K | 0.02% | 773 |
|
|
2024
Q4 | $2.88M | Sell |
19,100
-15,400
| -45% | -$2.4M | 0.02% | 696 |
|
|
2024
Q3 | $5.36M | Buy |
34,500
+22,740
| +193% | +$3.4M | 0.04% | 521 |
|
|
2024
Q2 | $1.61M | Buy |
+11,760
| New | +$1.61M | 0.01% | 1002 |
|
|
2023
Q4 | – | Sell |
-24,618
| Closed | -$3M | – | 1936 |
|
|
2023
Q3 | $3M | Buy |
+24,618
| New | +$3.28M | 0.02% | 702 |
|
|
2023
Q2 | – | Sell |
-8,417
| Closed | -$1.19M | – | 2214 |
|
|
2023
Q1 | $1.19M | Sell |
8,417
-8,448
| -50% | -$1.21M | 0.01% | 882 |
|
|
2022
Q4 | $2.64M | Buy |
16,865
+1,964
| +13% | +$282K | 0.02% | 709 |
|
|
2022
Q3 | $1.83M | Buy |
14,901
+3,639
| +32% | +$479K | 0.02% | 909 |
|
|
2022
Q2 | $1.5M | Sell |
11,262
-45,238
| -80% | -$6.16M | 0.01% | 842 |
|
|
2022
Q1 | $7.73M | Buy |
56,500
+50,339
| +817% | +$7.02M | 0.07% | 324 |
|
|
2021
Q4 | $1.07M | Sell |
6,161
-3,939
| -39% | -$599K | 0.01% | 905 |
|
|
2021
Q3 | $1.47M | Buy |
+10,100
| New | +$1.48M | 0.02% | 817 |
|
|
2021
Q1 | – | Sell |
-18,130
| Closed | -$2.16M | – | 1862 |
|
|
2020
Q4 | $2.16M | Sell |
18,130
-32,312
| -64% | -$3.94M | 0.03% | 582 |
|
|
2020
Q3 | $5.78M | Buy |
50,442
+32,466
| +181% | +$3.84M | 0.11% | 254 |
|
|
2020
Q2 | $2.05M | Sell |
17,976
-4,590
| -20% | -$487K | 0.05% | 398 |
|
|
2020
Q1 | $1.81M | Buy |
22,566
+7,652
| +51% | +$792K | 0.11% | 214 |
|
|
2019
Q4 | $1.59M | Sell |
14,914
-18,186
| -55% | -$1.9M | 0.04% | 384 |
|
|
2019
Q3 | $3.54M | Buy |
+33,100
| New | +$3.4M | 0.1% | 211 |
|
|
2018
Q4 | – | Sell |
-3,500
| Closed | -$378K | – | 1097 |
|
|
2018
Q3 | $378K | Sell |
3,500
-1,320
| -27% | -$145K | 0.02% | 641 |
|
|
2018
Q2 | $530K | Buy |
+4,820
| New | +$502K | 0.03% | 527 |
|
|
2018
Q1 | – | Sell |
-3,754
| Closed | -$370K | – | 801 |
|
|
2017
Q4 | $370K | Sell |
3,754
-55,432
| -94% | -$5.25M | 0.03% | 534 |
|
|
2017
Q3 | $5.54M | Buy |
59,186
+43,310
| +273% | +$4.6M | 0.51% | 55 |
|
|
2017
Q2 | $1.76M | Buy |
+15,876
| New | +$1.68M | 0.18% | 172 |
|
Other funds holding DGX
Steve Schonfeld's DGX Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Quest Diagnostics (DGX) in Q3 2026: 2,649 shares worth $617K. The stake represents ﹤0.01% of the portfolio and ranks #1865 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in DGX as recently as Q2 2025.
Steve Schonfeld first reported a position in DGX in Q2 2017 and has held it in 25 quarters since. The position peaked at $7.73M in Q1 2022. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Steve Schonfeld held 2,649 shares of Quest Diagnostics worth $617K as of Q3 2026.
- Quest Diagnostics was a new Steve Schonfeld position in Q3 2026.
- Quest Diagnostics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1865 holding.
- Steve Schonfeld first reported a position in Quest Diagnostics in Q2 2017 and has held it in 25 quarters since.
- Steve Schonfeld's Quest Diagnostics position peaked at $7.73M in Q1 2022.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.